A Study to Evaluate the Effects of the Neuroflo Device in People Who Have Had a Stroke "PAO"

Withdrawn

Phase 1 Results N/A

Summary of Purpose

Patients with acute ischemic stroke and persistent arterial occlusion following failed mechanical revascularization, who can undergo NeuroFlo treatment within 18 hours of last time symptom free, will be eligible for enrollment to assess the safety and feasibility of the NeuroFlo catheter in treating ischemic stroke... Trial Stopped: No Patients enrolled; sponsor not providing devices anymore

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 January 2013.

1 Mar 2008 2 Apr 2008 1 Mar 2013 1 Jun 2013 1 Jan 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Single Group Assignment

Contacts

  • 1st Contact: Ileana Grunberg, R.N. Phone: 310-794-0600 email: 2nd Contact: David Liebeskind, M.D. Phone: 310 794-6370 email: dliebeskind@mednet.ucla.edu

    igrunberg@mednet.ucla.edu